inducing and anti-proliferative effects of baicalein. As a 12-lipoxygenase inhibitor, baicalein induced apoptosis of a variety of human cancer cells such as breast cancer cells (Tong et al., 2002) , hepatoblastoma cells (Chang et al., 2002) , prostate cancer cells (Pidgeon et al., 2002) , and gastric cancer cells (Wong et al., 2001) . In many cases, the apoptogenic action of baicalein was associated with caspase activation, mitochondrial dysfunction, and modulation of Bcl-2 family proteins. Compared to well-known effects of baicalein on human cancer cells and its anti-inflammatory actions in peripheral inflammatory cells, little information is available about its effects on the inflammatory activation of microglia, their NO production, and apoptosis in central nervous system (CNS).
Microglia are a type of neuroglia that support, nurture, and protect the neurons maintaining homeostasis of the fluid that bathes neurons. Microglia function as macrophages in CNS; they migrate to area of injured nervous tissue, and they engulf and destroy microbes and cellular debris (Gehrmann et al., 1995) . Stimulated microglia produce diverse inflammatory mediators such as NO and TNFα. There is growing evidence that toxic mediators produced by activated microglial cells might be involved in the pathogenesis of various neurodegenerative diseases (Gonzalez-Scarano and Baltuch 1999; McGeer and McGeer 1995; Minghetti and Levi 1998) . Thus, in CNS, the production of toxic inflammatory mediators by activated microglial cells must be strictly regulated to avoid harmful effects. Potential mechanisms for downregulation of activated microglia may include the deactivation or elimination of activated cells. We and others have previously shown that activated microglial cells (Lee et al., 2001b; Liu et al., 2001 ) and astrocytes (Suk et al., 2001c) for the regulation of their own activation states, which is similar to activation-induced cell death (AICD) of lymphocytes. Because the process of auto-regulatory apoptosis of neuroglial cells heavily depends on autocrine NO production (Lee et al., 2001b; Suk et al., 2001c) , this type of programmed cell death may be either positively or negatively influenced by exogenous factors that stimulate or inhibit NO production. Wogonin, another flavonoid found in Scutellaria baicalensis Georgi, interfered with astrocyte AICD by inhibiting NO production (Kim et al., 2001a) . Based on the known antiinflammatory activities of baicalein, we hypothesized that baicalein may modulate NO production in microglial cells, which in turn may regulate apoptosis of activated microglial cells. In order to test this hypothesis we utilized BV-2 mouse microglial cells and rat primary microglia cultures which were activated with LPS and IFNγ in the presence or absence of baicalein, and evaluated the effects of the flavonoid on NO production as well as microglial apoptosis. We also investigated the mechanism(s) by which baicalein modulates auto-regulatory apoptosis of activated microglia with a focus on the apoptotic signaling pathways.
This article has not been copyedited and formatted. The final version may differ from this version. Bocchini at University of Perugia (Perugia, Italy) (Blasi et al., 1990) was generously provided by Dr. E. Choi at Korea University (Seoul, Korea). The cell line was maintained in DMEM supplemented with 5% FBS, 2 mM glutamine, and penicillinstreptomycin (Gibco-BRL, Gaithersburg, MD). Rat primary microglial cells were prepared as previously described with minor modifications (Aloisi et al., 1999; Lee et al., 2001a) . In brief, forebrains of newborn Sprague Dawley rats were chopped and dissociated by trypsinization and mechanical disruption. The cells were seeded into poly-L-lysine-coated flasks. After in vitro culture for 10 days, microglial cells were detached by rapid and gentle shaking of the culture flasks and seeded into plastic surfaces.
After an additional 1 hr incubation, non-adherent cells were removed by replacing culture This article has not been copyedited and formatted. The final version may differ from this version. ng/ml for LPS and 100 units/ml for IFNγ (Lee et al., 2001a; Lee et al., 2001b) . In some experiments, cells were pretreated with a caspase inhibitor or NAC for 1 hr before LPS/IFNγ treatment. After the treatment, the medium was removed and 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT, 0.5 mg/ml) was added, followed by incubation at 37°C for 2 hr in CO 2 incubator. After a brief centrifugation, supernatants were carefully removed and DMSO was added to the cells. After insoluble crystals were completely dissolved, absorbance at 540 nm was measured using Thermomax microplate reader (Molecular Devices, Sunnyvale, CA). For trypan blue exclusion assay, cell suspension was mixed with the same volume of 0.4% trypan blue solution (Gibco-BRL). Afterwards, the number of stained cells and the total number of cells were counted using hemocytometer (Marienfeld, Germany). Gel shift assays. Nuclear extracts were prepared from BV-2 cells as previously described (Schreiber et al., 1989 
Reverse transcription-polymerase chain reaction (RT-PCR).
Total RNA was extracted from cells by a sequential addition of 4 M guanidinium thiocyanate, 2 M sodium acetate, and acid phenol/chloroform. Reverse transcription was carried out using Superscript (Gibco-BRL) and oligo(dT) primer. PCR amplification using primer sets specific for caspase-11 or β-actin was carried out at 55°C annealing temperature for 25 cycles.
Nucleotide sequences of the primers were based on published cDNA sequences of mouse caspase-11 or β-actin: caspase-11 forward, CTT CAC AGT GCG AAA GAA CT; caspase-11 reverse, GGT CCA CAC TGA AGA ATG TCT GGA GAA GCA TTT CA; β-actin forward, ATC CTG AAA GAC CTC TAT GC; β-actin reverse, AAC GCA GCT CAG TAA CAG TC.
Assessment of caspase activity. Caspase-11-like activity was measured using a blue exclusion assays (100 ng/ml LPS treatment for 48 hr, 55.1 ± 2.3% cytotoxicity; 100 ng/ml LPS plus 10 µM baicalein treatment for 48 hr, 23.6 ± 4.1% cytotoxicity).
Treatment of BV-2 cells with either IFNγ or LPS plus IFNγ also induced NO production as well as cell death ( Fig. 2A, B) . However, baicalein did not affect NO production or microglial cell death following the treatment with IFNγ alone, indicating that the effects of baicalein were specific for the inflammatory stimulus that activated microglia.
Microglial cell death caused by the LPS treatment was due to apoptosis as determined by DNA ploidy analysis, and the reduction of cell death by baicalein was due to its antiapoptotic effects (Fig. 2C ). Apoptotic nature of LPS-induced microglial cell death has been well characterized in our previous report (including LPS time and dose responses, appearance of DNA ladder, and nuclear condensation, etc.) (Lee et al., 2001b) . The inhibitory effects of baicalein on LPS/IFNγ-induced NO production and subsequent cell death were similarly observed in rat primary microglia cultures, indicating that the AICD-attenuating effect of baicalein is not limited to a microglial cell line (Fig. 3) .
Because NO production in microglia is mostly controlled by the level of iNOS expression, we next examined the effects of baicalein on iNOS induction. Baicalein at 10 and 50 µM significantly inhibited LPS-induced iNOS protein levels indicating that the inhibitory effect of baicalein on microglial NO production was due to inhibition of iNOS induction (Fig. 4) .
Baicalein targets NF-κB to inhibit NO-dependent pathway of microglial AICD.
As the inflammatory induction of iNOS in neuroglial cells is known to be mediated mainly through NF-κB activation (Nomura 2001) , we speculated that baicalein may inhibit iNOS induction by down-regulating NF-κB activity in BV-2 cells. Gel shift assays indicated that LPS treatment of BV-2 cells strongly induced NF-κB activity, and this was inhibited by baicalein co-treatment suggesting that the inhibition of NF-κB may be an underlying mechanism of baicalein action on iNOS induction (Fig. 5A ).
NF-κB-inhibiting action of baicalein was confirmed by NF-κB reporter assays (Fig. 5B) .
A strong anti-oxidant NAC also inhibited LPS-induced NF-κB reporter activity.
Inhibition of NF-κB by baicalein was mainly due to the inhibition of nuclear translocation of NF-κB as demonstrated by Western blot analysis of nuclear fraction of microglial cells (Fig. 5C ). To further demonstrate the involvement of NF-κB in the AICD-inhibiting action of baicalein, BV-2 cells were transiently transfected with p65
subunit of NF-κB to enhance NF-κB activity, and then the effects of baicalein on microglial AICD were assessed. Forced expression of p65 increased NF-κB activity in BV-2 cells (Fig. 5D ), and this resulted in a complete abrogation of AICD-inhibiting activity of baicalein (Fig. 5E ). These results suggest that baicalein inhibits microglial AICD by inhibiting NF-κB, which is responsible for iNOS induction and subsequent NO production. Baicalein, however, did not significantly protect microglia against the exogenous NO donor (SNAP)-induced cytotoxicity (at 1 mM), although modest protective effects of baicalein were observed at low concentrations of SNAP (0.2 -0.5 mM) (Fig. 6A) . In contrast, a broad-spectrum caspase inhibitor, z-VAD-fmk, Therefore, one can speculate that the auto-regulatory apoptosis mechanisms that control microglial activation may exist in vivo, and the failure of these auto-regulatory mechanisms may be responsible for the deleterious effects of microglial activation. A pathophysiological importance of the regulation of microglial activation by AICD is supported by previous reports: up-regulated Bcl-x L expression has been detected in reactive microglia of patients with neurodegenerative diseases (Drache et al., 1997) ; and the expression of anti-apoptotic Bcl-2 protein has been associated with aged brain and neurodegenerative diseases (Migheli et al., 1994 We have shown that AICD-inhibiting action of baicalein is mediated through its inhibitory effects on iNOS induction and the ensuing NO production. This NOinhibiting effect of baicalein was based on the specific inhibition of NF-κB activity without affecting other known AICD pathways in microglia (Fig. 8) . The AICD of neuroglia (microglia and astrocytes) occurs by two separate apoptotic pathways;
inflammatory stimuli induce production of the autocrine toxic mediator (NO) in the IRF-1/NF-κB-dependent manner, and concurrently they initiate NO-independent apoptotic pathway through caspase-11 induction (Lee et al., 2001a; Suk et al., 2002) .
Increased expression of caspase-11 is known to auto-activate the protease, and then AICD does not play a cytoprotective role in contrast to previous studies conducted under different conditions (Beg and Baltimore 1996; Suk et al., 2001a; Wang et al., 1998; Wang et al., 1996) . With respect to the AICD of microglia, the main function of NF-κB appears to be the production of NO that acts as an autocrine mediator of apoptosis. Baicalein seems to selectively target this NF-κB activity in order to attenuate AICD of microglia. However, the AICD-inhibiting effect of baicalein was only partial due to the presence of NO-independent apoptotic pathways that are not affected by baicalein (Fig. 1D ).
The AICD-attenuating effect of baicalein in microglia was not dependent on 12-lipoxygenase inhibition. This was supported by the following evidence: a 12-lipoxygenase inhibitor without a known anti-oxidant activity, eicosatriynoic acid (Hammarstrom 1977) , did not reproduce the AICD-inhibitory effect of baicalein; and the predominant product of arachidonic acid metabolism of 12-lipoxygenase, 12(S)-HETE, did not reverse the inhibitory effect of baicalein. Although baicalein has been widely used as a 12-lipoxygenase inhibitor (Dailey and Imming 1999) , many reports also demonstrated strong anti-oxidant and free radical scavenging effects of baicalein (Gao et al., 1999; Hamada et al., 1993; Shieh et al., 2000) . Anti-oxidants are known to inhibit NF-κB activity in a variety of cell types (Christman et al., 2000) , and BV-2 was not an exception (Fig. 5B ). This led us to speculate that the anti-oxidant activity of baicalein might be responsible for the inhibition of NF-κB (and subsequent inhibition of NO production and AICD of microglia). Regardless of the relevance of 12-lipoxygenase inhibition to microglial AICD, baicalein might have inhibited 12-lipoxygenase activity in microglia under our experimental conditions. As opposed to This article has not been copyedited and formatted. The final version may differ from this version. Ishige et al., 2001; Lebeau et al., 2001 ). This suggests that the effect of 12-lipoxygenase inhibition on cell viability depends on the cell types studied; while a variety of human cancer cells in periphery undergo apoptosis upon exposure to 12-lipoxygenase inhibitor (Dailey and Imming 1999) , neurons and neuroglia in CNS may not be affected by 12-lipoxygenase inhibition.
Moreover, because baicalein has dual effects as a 12-lipoxygenase inhibitor and antioxidant, the flavonoid was able to protect microglia from AICD.
In the current study, baicalein showed a modest protective effect against SNAPinduced cytotoxicity. NO donors produce a range of reactive nitrogen intermediates (RNI), which may be related to cytotoxic effects of NO. Free radial scavenging activity of baicalein may be responsible for the protective effects against NO donors.
However, the protective effect of baicalein was observed only at low concentrations of SNAP, and the degree of protection was modest compared to the protective effects of baicalein on LPS-induced microglial cell death (Fig. 6A ). This further indicates that the AICD-attenuating effect of baicalein may be primarily due to the inhibition of NOproducing NF-κB rather than the blockade of cytotoxic action of NO produced. To obtain further evidence that NF-κB is the main target of baicalein action, we employed transient transfection of BV-2 cells with p65 subunit of NF-κB. The transfection led to an increase in NF-κB activity, which then abrogated the AICD-attenuating effect of baicalein ( Fig. 5D and E) . In conclusion, the plant flavonoid baicalein attenuated microglial AICD by selectively inhibiting NO-producing NF-κB activity. These effects of the flavonoid
were not related to 12-lipoxygenase inhibition. The AICD-inhibiting effect of baicalein was specific for the inflammatory stimulus in that the flavonoid blocked microglial NO production and cell death following the treatment with LPS, but not IFNγ.
Our results suggest that baicalein could be a key template for the development of therapeutic agents to selectively modulate inflammatory responses and cellular apoptosis in CNS.
This article has not been copyedited and formatted. The final version may differ from this version. activation, microglia undergo self-regulatory apoptosis by two separate signaling pathways. One is NO-dependent, that is, iNOS is induced by IRF-1 or NF-κB to give rise to massive NO production followed by apoptosis. The other is NO-independent pathway in that inflammatory stimuli induce activation of caspase-11, which in turn activates downstream executioner caspases for the induction of apoptosis. In this scheme, baicalein blocks AICD of microglia by targeting NF-κB. While the inhibition of NO-producing NF-κB is the main mechanism of action (solid line with '-'), apoptogenic action of NO may also be hindered by baicalein due to its anti-oxidant and free radical scavenging activity (broken line with '-').
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